IL6 and triple-negative breast carcinoma: Depending on the functional assay, Ki16425 inhibited the LPA-induced stimulation in triple-negative breast cancer and luminal A cell lines in a variable intensity and enhanced secretion of IL-8, IL-6 and TNF-alpha in MDA-MB-468 cells.